Introduction Over 11.5 million women suffer from infertility in the seven major markets. Although prevalence rates are stable, the trend towards later parenthood is inducing an increasing demand for infertility treatments. As cost of therapy is the major barrier access, the raise in demand puts increased pressure on healthcare payers to reimburse these treatments across the seven major markets.
Scope
Patient segmentation including detailed etiology of female and male infertility.
Analysis of presentation, diagnosis, and treatment trends as well patient referral pathways in each of the major regions.
In vitro fertilization treatment trends split by therapy protocol type, treatment regimen and drug class prescribed. Detailed IVF treatment outcomes.
Prescriber scoring of key drug brands on factors including efficacy, side effects, dosing flexibility, formulations, patient compliance, and cost.
Report
Highlights Prescribers perceive available IVF drugs are largely undifferentiated from each other. This allows physicians to prescribe according to personal preference and convenience, which means companies need to build strong relationships with physicians to increase brand loyalty.
Companies with urinary products need to strongly compete on a lower cost profile by lobbing with IVF payers and need to guarantee supply reliability. In Japan, where physicians prescribe 56% of follicle stimulating hormone and 80% of human chorionic gonadotropins in their urinary forms there is a clear opportunity for urinary companies.
The low scoring of Pergoveris (follitropin-alpha and luveris-alpha, Merck Serono) and Org36286 (corifollitropin-alpha, Organon) by survey respondents suggests that there is limited commercial potential for straightforward reformulations of existing drugs. There is a greater need for oral formulations.
Reasons
to Purchase
Target physicians more effectively through an understanding of prescribing behavior and its influences.
Validate new product forecasting based on diagnosis and treatment rates, and the likely rate of uptake for new products.
Benchmark brand awareness and perceptions surrounding product positioning in order to formulate competitive lifecycle management strategies.
Table
of Contents
Please click on the link below to view further information on this product (a new window
will open):
If you require further
information on this product or would like to purchase by invoice call our customer service
number:
(+1) 800-759-0261 or Email
us.
If you require assistance please Email
us or call +1-800-759-0261.
